Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Journal of Cancer

Showing results (81-90 of 5,561) with videos related to

Pageof 557
Sort By:
Journal of Cancer|April 20, 2012
Combination of the deacetylase inhibitor panobinostat and the multi-kinase inhibitor sorafenib for the treatment of metastatic hepatocellular carcinoma - review of the underlying molecular mechanisms and first case reportSusanne Gahr, Till Wissniowski, Steffen Zopf, et al.
Journal of Cancer|January 11, 2012
Diabetes and risk of renal cell carcinomaSamy L Habib, Thomas J Prihoda, Maria Luna, et al.
Journal of Cancer|April 7, 2012
A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast CancerXin Yao, Janet Hosenpud, Christopher R Chitambar, et al.
Journal of Cancer|April 22, 2011
Thyroid cancer: burden of illness and management of diseaseRebecca L Brown, Jonas A de Souza, Ezra Ew Cohen
Journal of Cancer|July 1, 2011
Sipuleucel-T: autologous cellular immunotherapy for men with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancerRobert B Sims
Journal of Cancer|July 1, 2011
Adoptive cell therapy for patients with melanomaMark E Dudley
Journal of Cancer|July 1, 2011
4th Edition of the International Autologous and Allogeneic Cell Therapy for Solid Tumors (ATST) MeetingMarco Bregni, Richard W Childs, Naoto T Ueno
Journal of Cancer|July 1, 2011
Primary mucinous adenocarcinoma of the vermiform appendix with high grade microsatellite instabilityMoritz Komm, Michaela Kronawitter-Fesl, Marcus Kremer, et al.
Journal of Cancer|August 19, 2011
Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of AktChandra Bartholomeusz, Fumiyuki Yamasaki, Hitomi Saso, et al.
Journal of Cancer|August 19, 2011
Tumor induced inactivation of natural killer cell cytotoxic function; implication in growth, expansion and differentiation of cancer stem cellsAnahid Jewett, Han-Ching Tseng
Pageof 557

Showing results (81-90 of 5,561) with videos related to

Sort By:
Pageof 557
Journal of Cancer|April 20, 2012
Combination of the deacetylase inhibitor panobinostat and the multi-kinase inhibitor sorafenib for the treatment of metastatic hepatocellular carcinoma - review of the underlying molecular mechanisms and first case reportSusanne Gahr, Till Wissniowski, Steffen Zopf, et al.
Journal of Cancer|January 11, 2012
Diabetes and risk of renal cell carcinomaSamy L Habib, Thomas J Prihoda, Maria Luna, et al.
Journal of Cancer|April 7, 2012
A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast CancerXin Yao, Janet Hosenpud, Christopher R Chitambar, et al.
Journal of Cancer|April 22, 2011
Thyroid cancer: burden of illness and management of diseaseRebecca L Brown, Jonas A de Souza, Ezra Ew Cohen
Journal of Cancer|July 1, 2011
Sipuleucel-T: autologous cellular immunotherapy for men with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancerRobert B Sims
Journal of Cancer|July 1, 2011
Adoptive cell therapy for patients with melanomaMark E Dudley
Journal of Cancer|July 1, 2011
4th Edition of the International Autologous and Allogeneic Cell Therapy for Solid Tumors (ATST) MeetingMarco Bregni, Richard W Childs, Naoto T Ueno
Journal of Cancer|July 1, 2011
Primary mucinous adenocarcinoma of the vermiform appendix with high grade microsatellite instabilityMoritz Komm, Michaela Kronawitter-Fesl, Marcus Kremer, et al.
Journal of Cancer|August 19, 2011
Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of AktChandra Bartholomeusz, Fumiyuki Yamasaki, Hitomi Saso, et al.
Journal of Cancer|August 19, 2011
Tumor induced inactivation of natural killer cell cytotoxic function; implication in growth, expansion and differentiation of cancer stem cellsAnahid Jewett, Han-Ching Tseng
Pageof 557